Blue reliever inhalers act quickly to treat symptoms and attacks, and people need to carry them for if their asthma flares up.However, a new warning from the regulator, the UK's Medicines and ...

Triple therapy inhalers are expected to account for 11.3% of the total market. The chronic obstructive pulmonary disease ...

Pressurized metered-dose inhalers (pMDIs) for COPD and asthma contribute to climate change, and countries are moving away from their use.